Related Experiment Video
Updated: Aug 19, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Coagulopathy screening in children with heparinized central venous catheters
1Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD.
Insights
A new method using protamine can screen for coagulopathy in blood drawn from heparinized central venous catheters, reducing patient discomfort by avoiding venipuncture.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- Central venous catheters are frequently used in clinical practice.
- Blood draws from heparinized catheters can be contaminated with heparin, affecting coagulation test results.
- Venipuncture for coagulation testing can cause discomfort and increase infection risk in patients with indwelling catheters.
Purpose of the Study:
- To develop and validate a screening method for coagulopathy using blood samples obtained from heparinized central venous catheters.
- To assess the efficacy of protamine in neutralizing heparin contamination in catheter-drawn blood for coagulation testing.
Main Methods:
- Paired blood samples were analyzed for prothrombin time (PT) and activated partial thromboplastin time (APTT) with and without protamine.
- Protamine was added at a concentration of 4 µg/mL to neutralize heparin in catheter samples.
- Samples were drawn from patients without known coagulopathy and from patients with coagulopathy.
Main Results:
- Uncorrected catheter samples showed a high rate of prolonged PT (44%) and APTT (52%).
- After protamine addition and correction, the rates of prolonged PT and APTT significantly decreased to 12% and 4%, respectively.
- The protamine-supplemented method correctly identified all four patients with known coagulopathy.
Conclusions:
- Protamine-supplemented APTT testing on blood from heparinized catheters is a viable screening method for coagulopathy.
- This approach minimizes patient discomfort by eliminating the need for venipuncture.
- It offers a practical alternative for monitoring coagulation status in patients with central venous catheters.
Objective:
To develop a method of screening for coagulopathy using blood drawn through heparinized central venous catheters.
Methods:
Prothrombin time (PT) and activated partial thromboplastin time (APTT) were determined in paired blood samples with and without the addition of protamine, using an automated photo-optical method. A concentration of 4 micrograms/mL of citrated whole blood was chosen, based on preliminary experiments. This is sufficient to neutralize the expected heparin contamination in samples drawn through heparinized catheters while causing only a slight prolongation in APTT (due to the anticoagulant effect of protamine). Seventeen paired samples were drawn by venipuncture in patients without known coagulopathy. Twenty-five samples were drawn through heparinized central venous catheters. The first 5 mL of blood drawn from a catheter was discarded to avoid gross heparin contamination. Four samples from patients with coagulopathy were also analyzed with and without the addition of 2.5 micrograms/mL of heparin.
Results:
Protamine increased PT by 9.0 +/- 0.8% and APTT by 9.0 +/- 3.4% (mean +/- SD) in the samples drawn by venipuncture. For samples drawn through heparinized catheters, 52% had a prolonged APTT, 44% a prolonged PT, and 68% had at least one prolonged test. With the addition of protamine, and after correction for the 9% mean increase in PT and APTT, 4% of samples had a prolonged APTT, 12% had a prolonged PT, and 16% had at least one prolonged test (P = .00006, .014, and .0001). All four samples from patients with coagulopathy were correctly identified as abnormal after the addition of protamine, with or without added heparin.
Conclusions:
A protamine-supplemented APTT test on blood drawn through a heparinized catheter may be an adequate screening test for coagulopathy. This procedure reduces discomfort in patients with an indwelling catheter by avoiding venipuncture.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

